Borage Oil.

Borage oil is the richest natural source of GLA, typically 20 to 24 percent of its fatty acids, so the two supply the identical omega-6 fatty acid the body elongates to dihomo-gamma-linolenic acid for eicosanoid production. Choosing one already delivers the other.

Both oils are used as dietary GLA sources that feed the same delta-6 desaturase bypass supporting normal skin barrier lipids and prostaglandin balance. Because borage is more GLA concentrated, stacking them mainly duplicates the same pathway rather than adding a distinct nutrient.

Borage oil's GLA and fish oil's EPA both move through the same elongase and desaturase enzymes toward eicosanoid precursors, and EPA helps keep GLA metabolism from drifting toward the arachidonic acid branch. The two essential fatty acid families are commonly paired to keep the omega-6 to omega-3 balance in a normal range.

The polyunsaturated GLA in borage oil oxidizes readily, and vitamin E is the fat soluble antioxidant that quenches the lipid peroxyl radicals which would otherwise degrade it. This is why softgels routinely include tocopherol to keep the oil stable and to spare the body's own antioxidant reserves.

Borage GLA elongates to dihomo-gamma-linolenic acid, and EPA slows delta-5 desaturase so less of that DGLA is converted onward to arachidonic acid. This is why GLA oils are conventionally formulated with a marine oil rather than alone.

DHA competes with n-6 fatty acids for incorporation into membrane phospholipids and for the shared desaturase and elongase enzymes. The balance of the two families, not the GLA dose alone, sets the fatty acid profile of the membrane.

Alpha-linolenic acid from flax and the n-6 chain from borage compete for the same delta-6 and delta-5 desaturases and elongases, so each lowers the throughput of the other. Combining them dilutes both conversions rather than adding them.

Zinc is required for normal delta-6 desaturase and elongase activity in the essential fatty acid pathway, which is the machinery that carries GLA onward to DGLA. Low zinc status blunts that step regardless of the GLA dose.

Pyridoxine status affects desaturase activity in the essential fatty acid pathway, placing it alongside zinc and magnesium as a cofactor for GLA handling. It supports conversion rather than supplying fatty acid.

Magnesium is one of the cofactors for the desaturase and elongase steps in fatty acid chain extension. It is included in GLA formulas for that supporting role.

Rosemary diterpenes such as carnosic acid are a standard oxidation inhibitor in polyunsaturated oil softgels, and borage oil is highly unsaturated and prone to peroxide formation. Stabilising the oil protects the GLA content on the shelf.

Tocotrienols work in the same lipid compartment as the oil and interrupt the peroxidation chain that degrades polyunsaturated fatty acids. They complement tocopherol rather than replacing it.

DGLA-derived mediators from GLA reduce platelet aggregation, and ginkgolides act on platelet activating factor signalling, so the two touch normal clotting by separate routes that combine. Worth flagging where both appear.

Garlic organosulfur compounds reduce platelet aggregation independently of the GLA route, so the effects run in the same direction in a formula carrying both. The mechanism is settled enough to state even without a combination study.

Linoleic acid is the upstream substrate that delta-6 desaturase converts to gamma-linolenic acid, the fatty acid borage oil already supplies. Large linoleic acid intakes occupy the same desaturase and elongase machinery that handles GLA downstream. The two compete for shared enzymes rather than reinforcing each other.

Borage oil is a triglyceride, and pancreatic lipase must hydrolyse it to monoglycerides and free fatty acids before absorption. Where lipase output is low, fat absorption is the rate-limiting step for any oil. Supplemental lipase addresses digestion, not the fatty acid profile itself.

Bile salts emulsify dietary oil into micelles so lipase can reach it and so the products can cross the enterocyte membrane. Without adequate bile flow, an oil capsule passes through less well absorbed. This is a general fat-absorption relationship rather than anything specific to gamma-linolenic acid.

Lecithin is a standard emulsifier for oil-in-water systems and is used to disperse seed oils in liquid and emulsion formats. A 2026 formulation paper on high-load borage oil nanoemulsions sits in the same territory of getting the oil into a stable dispersed phase. It changes handling and dispersion, not the fatty acid content.

Polyunsaturated oils oxidise readily, and mixed tocopherols are the usual chain-breaking antioxidant added to retard peroxide formation during storage. This is why most borage softgels list a tocopherol on the label. It protects the oil in the capsule and says nothing about an effect in the body.

Astaxanthin partitions into lipid membranes and the oil phase, where polyunsaturated fatty acids are most vulnerable to peroxidation. Pairing it with a highly unsaturated oil is a common formulation choice on that basis. The rationale is chemical; combined human data on the pair is not established.

The EPA in krill oil inhibits delta-5 desaturase, the step that converts dihomo-gamma-linolenic acid onward to arachidonic acid. Combining the two shifts the balance of the omega-6 series that borage oil feeds. Whether that is wanted depends entirely on the formulation's intent.

Nattokinase acts on fibrin and clot-related chemistry, and higher intakes of long-chain polyunsaturated fatty acids influence platelet behaviour. Stacking the two adds effects in the same direction. Worth flagging for anyone already on blood-thinning medication, which is a conversation for their clinician.

Salicin from willow bark is metabolised to salicylate, which inhibits platelet cyclooxygenase. Polyunsaturated oils act on the same eicosanoid system from the substrate side. The effects add rather than cancel.

Gingerols influence thromboxane-related platelet chemistry, the same pathway that dietary polyunsaturated fatty acids feed into as substrate. The combination is additive in direction. Flagged for awareness rather than avoidance.

Curcumin modulates cyclooxygenase and lipoxygenase activity, the enzymes that act on the fatty acids borage oil supplies. Both sides touch the same eicosanoid system, one as substrate and one as enzyme modulator. Effects add in the same direction.